stockrowAlkermes plc
ALKS Healthcare Drug Manufacturers Specialty & Generic
Alkermes plc’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 5.25% from fiscal 2024.
- Revenue
- +21.8%
- EPS
- −80.6%
- Free cash flow
- +6.78%
Quarter to September 2026, against a year earlier
Follow ALKS
Alert me
Alkermes plc (ALKS) Free cash flow
Alkermes plc's free cash flow for fiscal 2025 was $481.4M, up 18.5% from $406.1M in fiscal 2024. Over the twelve months to 30 September 2026 it was $228.4M. Over the past ten years it has ranged from −$107.3M (fiscal 2016) to $481.4M (fiscal 2025) — the current reading is the highest in ten years. Free cash flow has risen for 3 consecutive fiscal years. Alkermes plc ranks 13th of 84 Drug Manufacturers Specialty & Generic companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $481.4M | 18.55% |
| FY2024 | $406.1M | 14.83% |
| FY2023 | $353.7M | — |
| FY2022 | −$17.2M | — |
| FY2021 | $73.0M | 76.86% |
| FY2020 | $41.3M | — |
| FY2019 | −$18.0M | — |
| FY2018 | $30.4M | — |
| FY2017 | −$31.9M | — |
| FY2016 | −$107.3M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $90.1M | (34.27%) |
| Jun 2026 | $137.0M | — |
| Mar 2026 | −$169.8M | — |
| Dec 2025 | $171.1M | 102.87% |
| 43 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| LNTH Lantheus Holdings, Inc. compare | $409.5M |
| ELAN Elanco Animal Health Incorporated compare | $379.0M |
| ALKS Alkermes plc | $228.4M |
| KNSA Kiniksa Pharmaceuticals International, plc compare | $197.2M |
| LQDA Liquidia Corporation compare | $150.7M |
| RDY Dr. Reddy's Laboratories Ltd compare | $96.0M |
| HIMS Hims & Hers Health, Inc. compare | $83.0M |
| SUPN Indivior Pharmaceuticals Inc. compare | $31.0M |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | −$60.5M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on ALKS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement